BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31853610)

  • 1. Trends in Contralateral Prophylactic Mastectomy.
    Fairbairn K; Cervantes A; Rayhrer C; Steen S
    Aesthetic Plast Surg; 2020 Apr; 44(2):323-329. PubMed ID: 31853610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral Prophylactic Mastectomy in Patients with Breast Cancer.
    Noditi A; Caragheorghe G; Stoleru S; Blidaru A; Bordea CI
    Chirurgia (Bucur); 2021; 116(2 Suppl):73-83. PubMed ID: 33963696
    [No Abstract]   [Full Text] [Related]  

  • 4. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
    Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
    Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
    Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
    Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Contralateral Prophylactic Mastectomy and Other Types of Breast Cancer Surgery, South Carolina, 2005-2013.
    Clerville J; Bolick S; Clugstone S
    J Registry Manag; 2018; 45(1):28-32. PubMed ID: 30183694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends of Contralateral prophylactic mastectomy at the time of ipsilateral breast tumor recurrence.
    ElSherif A; Armanyous S; Gentle CK; Al-Hilli Z; Valente SA
    Am J Surg; 2022 Mar; 223(3):533-537. PubMed ID: 34924172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contralateral Prophylactic Mastectomy: Factors Predictive of Occult Malignancy or High-Risk Lesion and the Impact of MRI and Genetic Testing.
    Erdahl LM; Boughey JC; Hoskin TL; Degnim AC; Hieken TJ
    Ann Surg Oncol; 2016 Jan; 23(1):72-7. PubMed ID: 26065870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Moderate-Risk Breast Cancer Genes with Contralateral Prophylactic Mastectomy and Bilateral Disease.
    Zhang JQ; Dos Anjos CH; Sevilimedu V; Crown A; Amoroso KA; Pilewskie ML; Robson ME; Gemignani ML
    Ann Surg Oncol; 2023 Nov; 30(12):6990-6999. PubMed ID: 37661222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active Participation in Decision-Making in Contralateral Prophylactic Mastectomy for Patients With Breast Cancer.
    Huang J; Chagpar A
    J Surg Res; 2019 Oct; 242():129-135. PubMed ID: 31075657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral prophylactic mastectomy: A narrative review of the evidence and acceptability.
    Scheepens JCC; Veer LV'; Esserman L; Belkora J; Mukhtar RA
    Breast; 2021 Apr; 56():61-69. PubMed ID: 33621798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rate of contralateral prophylactic mastectomy is influenced by preoperative MRI recommendations.
    Xia C; Schroeder MC; Weigel RJ; Sugg SL; Thomas A
    Ann Surg Oncol; 2014 Dec; 21(13):4133-8. PubMed ID: 24934585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
    Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
    J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy.
    Yi M; Hunt KK; Arun BK; Bedrosian I; Barrera AG; Do KA; Kuerer HM; Babiera GV; Mittendorf EA; Ready K; Litton J; Meric-Bernstam F
    Cancer Prev Res (Phila); 2010 Aug; 3(8):1026-34. PubMed ID: 20647335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.